Novocure has filed an application asking the U.S. Food and Drug Administration to approve its Tumor Treating Fields (TTFields)…
Articles by Margarida Maia, PhD
The U.S. Food and Drug Administration (FDA) has given fast track status to stenoparib, an experimental treatment Allarity Therapeutics…
Geneseeq Technology is developing a blood test that uses cell-free DNA (cfDNA) and artificial intelligence (AI) to detect early-stage…
The European Commission has extended its approval of Johnson & Johnson’s Darzalex (daratumumab) for injection under the skin as…
Minimal residual disease or MRD — defined as a very small number of cancer cells that remain in the body…
Adding elraglusib, a small molecule being developed by Actuate Therapeutics, to standard chemotherapy with gemcitabine and nab-paclitaxel (GnP) as…
Treatment with Zynlonta (loncastuximab tesirine) is helping to push high-risk follicular lymphoma and marginal zone lymphoma into complete remission…
Bizengri (zenocutuzumab-zbco) is now approved in the U.S. as the first treatment for advanced pancreatic cancer and non-small cell…
Treovir has launched a Phase 2 clinical trial to assess the safety and efficacy of G207, an experimental virus-based…
Adding Keytruda (pembrolizumab) to chemotherapy, followed by maintenance treatment with Lynparza (olaparib), delayed cancer progression more effectively than…